2026, Volume 4, Issue 2

2026, Volume 4, Issue 2

June 2026

ACMG-Based Reclassification of TP53 Variants in Oncogenetic Practice

Elena BULANCEA, Stefania IORDACHE, Cerasela JARDAN, Onda-Tabita CALUGARU

2026 Vol. 4 Nr. 2
https://doi.org/10.59854/dhrrh.2026.4.2.43

Triple Therapy with Azacitidine, Venetoclax and Gilteritinib as a Therapeutic Option for Adult Patients with Refractory/Relapsed FLT3 Mutated Acute Myeloid Leukemia – A Single Center Experience

Dana FRANGU, Roxana HIRJAN, Bianca CONSTANTIN, Andreea ANDRUNACHE, Mihaela CIRSTEA, Bogdan IONESCU, Camelia STANCIOAICA, Alexandra GHIAUR, Aurelia TATIC

2026 Vol. 4 Nr. 2
https://doi.org/10.59854/dhrrh.2026.4.2.49

Prognostic Factors in Polycythemia Vera

Sandor-Szilard PORTIK, Laura URIAN, Mihnea ZDRENGHEA, Anca VASILACHE, Tunde TOROK, Andrada PARVU, Ciprian TOMULEASA, Delia DIMA, Ioana RUS, Oana MESAROS, Laura JIMBU, Anca BOJAN

2026 Vol. 4 Nr. 2
https://doi.org/10.59854/dhrrh.2026.4.2.67

Challenges in the management of DLBCL in Pregnancy – A Case Report

Stefan-Antoniu AIONESE, Mihaela CIRSTEA, Oana RIZEA, Aurelia TATIC

2026 Vol. 4 Nr. 2
https://doi.org/10.59854/dhrrh.2026.4.2.91

ISSN-online 2972-242X

ISSN-L 2972-242X

ISSN-print 3008-220X